| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |